S&P 및 Nasdaq 내재가치 문의하기

Pieris Pharmaceuticals, Inc. PIRS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
36/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Pieris Pharmaceuticals, Inc. (PIRS), 포함 42 건 매수5 건 매도. 내부자 매수 총액은 $12.03M 내부자 매도 총액은 $2.66M.

최근 활동이 있는 주요 내부자에는 Geraghty James A, Kiritsy Christopher P, Dellora Investments Lp. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.

내부자 거래 내역 — PIRS

날짜 이름 직책 거래 유형 주식수 평균 가격 금액 보유 주식수
2024-12-12 Geraghty James A Director 주식 반환 1 $0.01 $0.01 -
2024-12-02 Kiritsy Christopher P Director RSU 부여 500 $16.43 $8.22K 500
2024-11-06 Dellora Investments Lp 10 Percent Owner 알 수 없음 - - - 141,079
2024-08-12 Adar1 Capital Management, Llc 10 Percent Owner 정보 매수 757 $15.88 $12.02K 15,067
2024-08-09 Adar1 Capital Management, Llc 10 Percent Owner 정보 매수 3,000 $14.89 $44.68K 127,331
2024-08-07 Geraghty James A Director 정보 매수 1 $1.00 $1.00 1
2024-07-24 Adar1 Capital Management, Llc 10 Percent Owner 알 수 없음 - - - 14,310
2023-06-21 Geraghty James A Director RSU 부여 45,000 $0.26 $11.7K 45,000
2023-06-21 Kiritsy Christopher P Director RSU 부여 40,000 $0.26 $10.4K 40,000
2023-06-21 Sherman Matthew L Director RSU 부여 40,000 $0.26 $10.4K 40,000
2023-06-21 Kiener Peter A Director RSU 부여 40,000 $0.26 $10.4K 40,000
2023-06-21 Richman Michael Director RSU 부여 40,000 $0.26 $10.4K 40,000
2023-06-21 Barbier Ann Director RSU 부여 40,000 $0.26 $10.4K 40,000
2023-06-21 Said Maya R. Director RSU 부여 40,000 $0.26 $10.4K 40,000
2023-05-25 Kiritsy Christopher P Director 정보 매수 10,000 $0.85 $8.5K 20,000
2023-05-11 Bvf Partners L P/il 10 Percent Owner 처분 265,000 $7.10 $1.88M -
2023-02-24 Yoder Stephen S. Chief Executive Officer RSU 부여 634,021 $1.39 $881.29K 634,021
2023-02-24 Bures Thomas Chief Financial Officer RSU 부여 249,080 $1.39 $346.22K 249,080
2023-02-24 Kaufmann Hitto Chief Scientific Officer RSU 부여 249,080 $1.39 $346.22K 249,080
2023-02-24 Olwill Shane Chief Development Officer RSU 부여 249,080 $1.39 $346.22K 249,080
2023-02-24 Mousa Ahmed Chief Business Officer RSU 부여 249,080 $1.39 $346.22K 249,080
2022-06-22 Geraghty James A Director RSU 부여 45,000 - - 45,000
2022-06-22 Kiritsy Christopher P Director RSU 부여 40,000 $1.82 $72.8K 40,000
2022-06-22 Sherman Matthew L Director RSU 부여 40,000 - - 40,000
2022-06-22 Kiener Peter A Director RSU 부여 40,000 - - 40,000
2022-06-22 Richman Michael Director RSU 부여 40,000 - - 40,000
2022-06-22 Barbier Ann Director RSU 부여 40,000 $1.82 $72.8K 40,000
2022-06-22 Said Maya R. Director RSU 부여 40,000 - - 40,000
2022-05-13 Demuth Tim Chief Medical Officer 정보 매수 6,000 $1.71 $10.26K 6,000
2022-02-22 Yoder Stephen S. Chief Executive Officer RSU 부여 625,874 $3.03 $1.9M 625,874
2022-02-22 Bures Thomas Chief Financial Officer RSU 부여 215,819 $3.03 $653.93K 215,819
2022-02-22 Kaufmann Hitto SVP, Chief Scientific Officer RSU 부여 215,819 $3.03 $653.93K 215,819
2022-02-22 Demuth Tim Chief Medical Officer RSU 부여 100,000 $3.03 $303K 100,000
2022-02-22 Olwill Shane Chief Development Officer RSU 부여 215,819 $3.03 $653.93K 215,819
2022-02-22 Mousa Ahmed Chief Business Officer RSU 부여 215,819 $3.03 $653.93K 215,819
2021-10-06 Mousa Ahmed Chief Business Officer 처분 150,000 $2.50 $375K -
2021-08-30 Olwill Shane Chief Development Officer 정보 매도 29,200 $5.15 $150.38K 4,638
2021-08-01 Demuth Tim Officer 알 수 없음 - - - -
2021-08-01 Demuth Tim Chief Medical Officer RSU 부여 360,000 $3.48 $1.25M 360,000
2021-08-01 Olwill Shane Chief Development Officer 처분 82,000 $3.09 $253.38K -
2021-06-25 Geraghty James A Director RSU 부여 45,000 $4.00 $180K 45,000
2021-06-25 Kiritsy Christopher P Director RSU 부여 40,000 $4.00 $160K 40,000
2021-06-25 Sherman Matthew L Director RSU 부여 40,000 $4.00 $160K 40,000
2021-06-25 Kiener Peter A Director RSU 부여 40,000 $4.00 $160K 40,000
2021-06-25 Richman Michael Director RSU 부여 40,000 $4.00 $160K 40,000
2021-06-25 Barbier Ann Director RSU 부여 40,000 $4.00 $160K 40,000
2021-06-25 Said Maya R. Director RSU 부여 40,000 $4.00 $160K 40,000
2021-03-04 Yoder Stephen S. Chief Executive Officer RSU 부여 530,000 $2.50 $1.33M 530,000
2021-03-04 Bures Thomas Vice President, Finance RSU 부여 150,000 $2.50 $375K 150,000
2021-03-04 Kaufmann Hitto SVP, Chief Scientific Officer RSU 부여 220,000 $2.50 $550K 220,000
정보 기반 — 공개 시장 거래 (가장 중요) 비정보 매수 — 보상, 옵션 행사, 전환 비정보 매도 — 세금 원천징수, 부여 매도 중립 — 증여, 신탁, 만료
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
메시지 보내기